←Back to Expert Scholars
Translational Medicine / 转化医学BCMA-Targeted Myeloma Therapy
Yi Lin
MD, PhD
🏢Mayo Clinic🌐USA
Professor of Medicine, Division of Hematology
48
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Yi Lin is a hematologist and cellular therapy expert who has led important clinical trials of BCMA-targeted CAR-T cells for multiple myeloma. Her research on CRS and neurotoxicity management has improved the safety profile of cellular therapies. She has contributed to expanding CAR-T access through multicenter real-world evidence studies.
Share:
🧪Research Fields 研究领域
CAR-T cell therapy
BCMA targeting
Lymphoma immunotherapy
Cellular therapy toxicity
Clinical hematology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Yi Lin 的研究动态
Follow Yi Lin's research updates
留下邮箱，当我们发布与 Yi Lin（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment